| ROY, Sudeep, Akhil KUMAR, Mohd Hassan BAIG, Michal MASAŘÍK and Ivo PROVAZNÍK. Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease. Methods. San Diego: Academic Press Inc. Elsevier Science, 2015, vol. 83, "15 July 2015", p. 105-110. ISSN 1046-2023. Available from: https://dx.doi.org/10.1016/j.ymeth.2015.04.021. |
Other formats:
BibTeX
LaTeX
RIS
@article{1311834,
author = {Roy, Sudeep and Kumar, Akhil and Baig, Mohd Hassan and Masařík, Michal and Provazník, Ivo},
article_location = {San Diego},
article_number = {"15 July 2015"},
doi = {http://dx.doi.org/10.1016/j.ymeth.2015.04.021},
keywords = {Alzheimer's disease; Metallothionein-III; Virtual screening; ADMET; Molecular dynamics},
language = {eng},
issn = {1046-2023},
journal = {Methods},
title = {Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease},
volume = {83},
year = {2015}
}
TY - JOUR
ID - 1311834
AU - Roy, Sudeep - Kumar, Akhil - Baig, Mohd Hassan - Masařík, Michal - Provazník, Ivo
PY - 2015
TI - Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease
JF - Methods
VL - 83
IS - "15 July 2015"
SP - 105-110
EP - 105-110
PB - Academic Press Inc. Elsevier Science
SN - 10462023
KW - Alzheimer's disease
KW - Metallothionein-III
KW - Virtual screening
KW - ADMET
KW - Molecular dynamics
N2 - Motivation: Metallothionein-III (MT-III) displays neuro-inhibitory activity and is involved in the repair of neuronal damage. An altered expression level of MT-III suggests that it could be a mitigating factor in Alzheimer's disease (AD) neuronal dysfunction. Currently there are limited marketed drugs available against MT-III. The inhibitors are mostly pseudo-peptide based with limited ADMET. In our present study, available database InterBioScreen (natural compounds) was screened out for MT-III. Pharmacodynamics and pharmacokinetic studies were performed. Molecular docking and simulations of top hit molecules were performed to study complex stability. Results: Study reveals potent selective molecules that interact and form hydrogen bonds with amino acids Ser-6 and Lys-22 are common to established melatonin inhibitors for MT-III. These include DMHMIO, MCA B and s27533 derivatives. The ADMET profiling was better with comparable interaction energy values. It includes properties like blood brain barrier, hepatotoxicity, druggability, mutagenicity and carcinogenicity. Molecular dynamics studies were performed to validate our findings.
ER -
ROY, Sudeep, Akhil KUMAR, Mohd Hassan BAIG, Michal MASAŘÍK and Ivo PROVAZNÍK. Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease. \textit{Methods}. San Diego: Academic Press Inc. Elsevier Science, 2015, vol.~83, ''15 July 2015'', p.~105-110. ISSN~1046-2023. Available from: https://dx.doi.org/10.1016/j.ymeth.2015.04.021.
|
